DR. JULIA MARIA BIERNOT M.D.
Prescription History 1700034113
Psychiatry & Neurology - Neurology in Peoria, IL


Quality Rating: 100 out of 100 score

NPI Status: Active since August 28, 2008

Contact Information

100 NE RANDOLPH AVE
PEORIA, IL
ZIP 61606
Phone: (309) 624-8500
Fax: (309) 624-8552

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JULIA MARIA BIERNOT M.D., an active Neurology specialist practicing in Peoria, IL. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 208 documented patient claims. Among these therapy options, the most frequently utilized medication is Donepezil Hcl, which accounts for 110 claims alone.

Medication Index


Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 11
30-Day Fills 27.0
Days Supply 810
IL State Average Benchmarks
Peer Average Claims191.0
Peer Average 30-Day Fills466.6
Peer Average Days Supply13,780
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 94.2% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $180.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.42

State Avg Cost Per Claim

$12.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 110
30-Day Fills 309.3
Days Supply 9,280
IL State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills101.8
Peer Average Days Supply2,788
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 74.6% higher than the standard regional baseline profile for IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,512.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.84

State Avg Cost Per Claim

$14.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Escitalopram Oxalate

Generic Formulation: Escitalopram OxalateSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 18
30-Day Fills 34.0
Days Supply 1,020
IL State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills106.3
Peer Average Days Supply3,065
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.9% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $255.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.21

State Avg Cost Per Claim

$16.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

S-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.

Therapeutic Applications

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. Escitalopram belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI). It may improve your energy level and feelings of well-being and decrease nervousness.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 45
30-Day Fills 94.9
Days Supply 2,848
IL State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills84.4
Peer Average Days Supply2,244
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,907.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$64.62

State Avg Cost Per Claim

$49.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Neuropsychiatry
Provider Metrics Summary
Total Claims 24
30-Day Fills 72.0
Days Supply 2,160
IL State Average Benchmarks
Peer Average Claims64.0
Peer Average 30-Day Fills116.8
Peer Average Days Supply3,357
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 62.5% less volume than the regional standard for practitioners inside IL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $173.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.24

State Avg Cost Per Claim

$10.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. JULIA MARIA BIERNOT M.D. provides transparency into local medical care patterns within Peoria, IL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.